N

    NeuroSense Therapeutics Ltd. Warrant (NRSNW)

    Official site

    BIOTECHNOLOGY • NASDAQ

    $0.05
    -0.02 (-28.57%)

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Upcoming Estimates

    Period ending Mar 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    Period ending Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26EST
    		-N/A---
    Mar 26EST
    		-N/A---
    Mar 21
    Reported Jun 30
    		$-0.27$0.00N/AMiss-372.8%
    Dec 20
    Reported Mar 31
    		$-0.27$0.00N/AMiss-372.8%
    Sep 20
    Reported Dec 31
    		$-0.20$0.00N/AMiss-
    Jun 20
    Reported Sep 30
    		$-0.20$0.00N/AMiss-
    Mar 20
    Reported Jun 30
    		$-0.06$0.00N/AMiss-
    Dec 19
    Reported Mar 31
    		$-0.06$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.05EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-2175.00%ROIC690.90%
    Financial Health
    Debt/Equity-0.06xInterest Coverage-277.96x
    Current Ratio0.31xQuick Ratio0.31x
    Trading Statistics
    Beta1.60Avg Volume648
    52-Week High$0.7052-Week Low$0.04

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.05
    SMA 20$0.08
    SMA 50$0.09
    SMA 200$0.20
    EMA 10$0.06
    EMA 20$0.07
    EMA 50$0.09
    EMA 200$0.19

    MACD

    Line: -0.01Signal: -0.01Hist: -0.00

    ADX

    ADX: 24.8+DI: 30.8-DI: 52.8

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down76.0
    PSAR$0.10

    Bollinger Bands

    Upper Band$0.16
    Lower Band$0.01
    %B Position18204%(Upper)
    Band Width0.28

    RSI (14-Day)

    Neutral
    39.7

    Momentum Oscillators

    Stoch %K30.4
    Stoch %D23.3
    Williams %R-86.3
    ROC (10d)-33.3%
    Momentum-0.03
    CCI (20d)-66.2
    MFI (14d)8.9

    Volatility Measures

    ATR (14d)$0.01(27.8%)
    StdDev (20d)0.04
    Hist Vol362.9%(High)

    Volume Flow

    VWAP$0.05
    OBV-28.0K
    AD Line28.4K
    CMF (20d)0.180

    Volume Metrics

    Avg Vol (20d)0.7K
    Vol Ratio0.0x(Low)
    VWMA (20d)$0.06

    Pivot Points

    R3$0.10
    R2$0.09
    R1$0.08
    Pivot Point$0.06
    S1$0.05
    S2$0.04
    S3$0.03

    Advanced Oscillators

    TSI-18.87
    Ultimate Osc57.4
    KST-333.62

    Financial Data

    QuarterDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total RevenueN/AN/AN/AN/A$0$0$0$0$0$0$0$0
    Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Operating Expenses$3.20M$3.20M$2.35M$2.35M$1.77M$2.11M$3.03M$2.99M$3.29M$2.90M$3.48M$2.99M
    R&D$1.86M$1.86M$1.25M$1.25M$1.09M$1.16M$1.57M$1.88M$1.96M$1.63M$1.91M$1.85M
    SG&A$1.33M$1.33M$1.09M$1.09M$685,000$946,000$1.46M$1.11M$1.33M$1.27M$1.57M$1.14M
    Operating Income$-3,196,500$-3,196,500$-2,346,000$-2,346,000$-1,771,000$-2,107,000$-3,030,000$-2,994,000$-3,287,000$-2,897,000$-3,477,000$-2,991,000
    Interest Income$0$0$0$0$0$0$0$0$3.71M$0$0$62,000
    Interest Expense$11,500$11,500$8,500$8,500$30,000$41,000$2.17M$2.41M$2.20M$12,000$276,000$310,000
    Income Before Tax$-3,208,000$-3,208,000$-2,354,500$-2,354,500$-1,801,000$-2,148,000$-857,000$-5,404,000$-2,950,000$784,000$-5,225,000$-2,924,000
    Income Tax Expense$0$0$0$0$0$0$0$-43,276$0$5.92M$-2,174,000$-62,000
    Net Income$-3,208,000$-3,208,000$-2,354,500$-2,354,500$-1,801,000$-2,148,000$-857,000$-5,404,000$-2,950,000$784,000$-5,225,000$-2,924,000
    EBITDA$-3,192,500$-3,192,500$-2,342,000$-2,342,000N/A$-2,101,750$-851,500$-2,988,750N/A$2.99M$-5,505,500$-2,611,000
    EBIT$-3,196,500$-3,196,500$-2,346,000$-2,346,000N/A$-2,107,000$-857,000$-2,994,000N/A$793,000$-5,529,000$-2,614,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NRSNW

    News

    No news available

    Company news will appear here when available

    Frequently Asked Questions About NRSNW

    Does NRSNW pay dividends?
    NeuroSense Therapeutics Ltd. Warrant (NRSNW) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In